X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    development of new antibiotics

    EMA guidance supports development of new antibiotics

    Thermo Fisher Scientific Announces Collaboration with Northeastern University to Advance Biopharmaceutical Characterization and Monitoring Workflows

    Commercial Success In New Biopharmaceutical Innovation Era

    Proteros and AstraZeneca Boost Collaboration Agreement

    Conver to wp

    AbbVie and Cugene Join Forces Concerning Autoimmune Disorders and Cancer

    Drug Imagent For Therapeutic Platform

    Japan Pharma Lobby Says-Price Scheme Is Causing Drug Lag

    Charles River and Valence Discovery Announce Strategic Partnership to Provide Clients with AI-Enabled Drug Design Capabilities

    Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets

    AstraZeneca announces phase IV ASCENT trial of Tudorza Pressair in patients with COPD meets primary efficacy endpoint

    AstraZeneca announces plans for new strategic R&D centre and Alexion headquarters in Cambridge, Massachusetts

    Lynparza approved in the EU for BRCA-mutated metastatic pancreatic cancer

    Major Success Factors For Clinical Development Organizations

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

    ArisGlobal Expands LifeSphere Clinical Portfolio with Landmark Customer Wins in APAC & Middle East

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Middle East and South Asia

Vienna International Airport signs partnership agreement with Kuehne + Nagel on pharma freight handling

Content Team by Content Team
18th July 2019
in Middle East and South Asia, Packaging & Logistic, Press Statements
Vienna International Airport pharma freight handling

The quick and highly specialised handling of temperature-sensitive pharma products directly from aircraft to the roadways or vice versa is the core competence of the new 1,600 sqm Vienna Pharma Handling Center (VPHC). This makes Vienna International Airport the only airport in Central Europe to offer a complete end-to-end solution for pharma products from one single source, featuring a seamless cool chain, quick handling processes and short turnaround times between air and road transport.

Kuehne + Nagel is now utilising this highly specialised service as “Preferred Partner” for the handling of its pharma shipments. Within the framework of the partnership, the global logistics provider benefits from its own, exclusive handling area, allowing for even greater flexibility.

„Quick and efficient cargo handling is a key success factor in international freight transport. Thanks to the new Pharma Handling Center, 23 countries can now be reached within a day and a half, and fifteen countries can even be supplied within 24 hours of travel time via the Vienna pharma hub. We are delighted that Kuehne + Nagel relies on VIE‘s flexibility and operational excellence”, states Julian Jäger, member of the Management Board (COO) of Flughafen Wien AG.

Heiko Schuhmacher, Regional Airfreight Manager at Kuehne + Nagel: „This partnership between Kuehne + Nagel and the Vienna International Airport will further enhance service levels for our customers from the pharma & healthcare industry in Austria and the neighbouring countries. By using Kuehne + Nagel’s KN PharmaChain customers gain access to industry-specific, GxP compliant transport and logistics solutions with the same high quality standards worldwide.”

Patrick Mair, National Airfreight Manager at Kuehne + Nagel Austria: „All services such as packaging, storage, loading and unloading of temperature-controlled shipments can now be offered in an exclusive handling area. An additional benefit of the partnership is the fact that the facility is situated directly at the apron with very short tarmac distances to all aircraft positions. This enables a continuous cold chain for our shipments and seamless, temperature-controlled transportation to and from the aircraft, which was not previously available at Vienna International Airport.”

Das Vienna Pharma Handling Center was opened in December 2018. It is part of the Air Cargo Center and directly accessible from both, land and airside areas. The state-of-the-art facility provides two separate temperature controlled areas: A 1,600 sqm CRT (Controlled Room Temperature) area for the handling of pharmaceuticals at 15° – 25°C und an additional 153 sqm for the storage, build-up and break down of 2° – 8°C shipments. The VPHC exclusively handles temperature-sensitive pharmaceutical products. Vienna Airport has invested about €1.8 million in the new Pharma Handling Centre.

More information on the Vienna Pharma Handling Center:
www.viennaairport.com/pharmahandling

About Kuehne + Nagel
With over 82,000 employees at some 1,300 locations in over 100 countries, the Kuehne + Nagel Group is one of the world’s leading logistics companies. Its strong market position lies in the seafreight, airfreight, contract logistics and overland businesses, with a clear focus on providing IT-based integrated logistics solutions. In Austria, Kuehne + Nagel Kuehne + Nagel Austria has been operating since 1970, with approximately 500 employees at 12 locations. Further information can be found at www.kuehne-nagel.com.

Previous Post

Getinge and IMA Life create flexible solutions for the pharma and biopharma industries

Next Post

Novartis key multiple sclerosis product Gilenya approved in China

Related Posts

Dupixent From Sanofi Delivers Another Fantastic Performance
Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

5th July 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

Singapore Authorises New Ovarian Cancer Treatment By GSK

5th July 2022
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
Manufacturing

Abbott India Affirms That The Medicines Are Not Their Own

5th July 2022
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Manufacturing

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

4th July 2022
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
Manufacturing

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

4th July 2022
COVID-19 Omicron-Specific Vaccines Could Be Used As Boosters
Manufacturing

COVID-19 Omicron-Specific Vaccines Could Be Used As Boosters

4th July 2022
Next Post
Novartis Gilenya

Novartis key multiple sclerosis product Gilenya approved in China

Latest News

Dupixent From Sanofi Delivers Another Fantastic Performance
Manufacturing

Sanofi Sets Up Fund To Enable Firms In Low-Income Countries

5th July 2022
GSK commences phase III study of Benlysta and rituximab combination in systemic lupus erythematosus
Manufacturing

Singapore Authorises New Ovarian Cancer Treatment By GSK

5th July 2022
Abbott Is Named Global Industry Leader in Sustainability for the Sixth Consecutive Year on the Dow Jones Sustainability Index (DJSI)
Manufacturing

Abbott India Affirms That The Medicines Are Not Their Own

5th July 2022
Global Biopharmaceutical Bioseparation Market Eyeing $20bn
Manufacturing

Global Biopharmaceutical Bioseparation Market Eyeing $20bn

4th July 2022
FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters
Manufacturing

FDA Advises Adding Omicron BA.4, 5 To COVID-19 Boosters

4th July 2022
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In